XML 75 R44.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Business Combinations - Pro Forma Financial Information (Details) - InPharmics
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2017
USD ($)
$ / shares
shares
Business Acquisition [Line Items]  
Pro forma net revenues $ 713,272
Pro forma net income $ 30,683
Pro forma net income per share (in dollars per share) | $ / shares $ 0.82
Weighted-average number of shares (in shares) | shares 37,483